Market revenue in 2023 | USD 17.8 million |
Market revenue in 2030 | USD 33.5 million |
Growth rate | 9.5% (CAGR from 2023 to 2030) |
Largest segment | Tavr (transcatheter aortic valve replacement) |
Fastest growing segment | LAAC (Left Atrial Appendage Closure) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | SAVR (Surgical Aortic Valve Replacement), TAVR (Transcatheter Aortic Valve Replacement), Mitral Repair (Annuloplasty), LAAC (Left Atrial Appendage Closure) |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Edwards Lifesciences Corp, Abbott Laboratories, St. Jude Medical, LivaNova PLC, Stryker Corp, Lepu Medical, Biomerics, CardioKinetix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to structural heart devices market will help companies and investors design strategic landscapes.
Tavr (transcatheter aortic valve replacement) was the largest segment with a revenue share of 52.81% in 2023. Horizon Databook has segmented the Kuwait structural heart devices market based on savr (surgical aortic valve replacement), tavr (transcatheter aortic valve replacement), mitral repair (annuloplasty), laac (left atrial appendage closure) covering the revenue growth of each sub-segment from 2018 to 2030.
The structural heart devices market in Kuwait is experiencing significant growth and is expected to continue expanding in the coming years. The healthcare sector in Kuwait has witnessed notable advancements, leading to an increase in the number of cardiac surgeries performed and a rising demand for cardiovascular devices, including structural heart devices like cardiac catheters.
This growth is primarily driven by factors such as the escalating burden of CVDs, rapid technological innovations, and a surge in demand for cardiac procedures due to improved healthcare services and heightened awareness about heart conditions.
The market's momentum is further supported by impactful initiatives such as the Arab Health 2022 exhibition, where major medical technology firms showcase innovative products like the Hugo RAS system. The modernization of major healthcare complexes, which now offer state-of-the-art cardiology departments, has significantly transformed Kuwait's healthcare landscape.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait structural heart devices market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait structural heart devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account